HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$14.90+0.05 (+0.34%)
Close on Nov 13, 2026Market cap $2.60BP/E 5.7Yield –
HUTCHMED (China) operating margin
Operating margin is operating income as a percentage of revenue.
HUTCHMED (China)'s operating margin for the twelve months ending Dec 31, 2019 was -71.4%. For fiscal 2025 it was -7.1%, against -6.9% the year before. The highest annual figure on record is 2.2% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -7.1% | −0.2 |
| FY2024 | Dec 31, 2024 | -6.9% | −9.1 |
| FY2023 | Dec 31, 2023 | 2.2% | +97.8 |
| FY2022 | Dec 31, 2022 | -95.6% | −3.4 |
| FY2021 | Dec 31, 2021 | -92.2% | −5.9 |
| FY2020 | Dec 31, 2020 | -86.3% | −14.8 |
| FY2019 | Dec 31, 2019 | -71.4% | −28.2 |
| FY2018 | Dec 31, 2018 | -43.3% | −21.1 |
| FY2017 | Dec 31, 2017 | -22.1% | −0.5 |
| FY2016 | Dec 31, 2016 | -21.6% | −16.1 |
| FY2015 | Dec 31, 2015 | -5.5% | +15.4 |
| FY2014 | Dec 31, 2014 | -20.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | -72.0% | −26.5 |
| Q3 FY2019 | Sep 30, 2019 | -72.8% | −47.7 |
| Q2 FY2019 | Jun 30, 2019 | -71.9% | −14.4 |
| Q1 FY2019 | Mar 31, 2019 | -69.1% | −21.3 |
| Q4 FY2018 | Dec 31, 2018 | -45.5% | – |
| Q3 FY2018 | Sep 30, 2018 | -25.1% | – |
| Q2 FY2018 | Jun 30, 2018 | -57.5% | – |
| Q1 FY2018 | Mar 31, 2018 | -47.8% | – |
See a number that looks wrong?